ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

ROCKVILLE, Md., June 2, 2026 /PRNewswire/ -- CirrusDx, Inc. (CirrusDx), an infectious disease laboratory and diagnostics company, today announced it now offers antimicrobial susceptibility testing ...

In a multinational randomized trial, rapid antimicrobial susceptibility testing (AST) shortened the time to antibiotic modification in patients with gram-negative bacteremia but did not improve the ...

The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...

In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic ...

Antimicrobial resistance (AMR) directly causes an estimated 1.3 million deaths around the globe annually, a figure that the World Health Organization has predicted will rise. A leading cause of AMR is ...

Bloodstream infections are among the most dangerous conditions clinicians face, capable of spiralling into sepsis within ...

A new method for identifying the pathogens involved in sepsis cases, which could help to select optimal therapeutics, is reported in Nature. The test has the potential to reduce the turnaround times ...

Please provide your email address to receive an email when new articles are posted on . A randomized clinical trial of rapid antibiotic susceptibility testing produced mixed results. It did not ...

The possibility of rapidly identifying antibiotic resistant bacteria can play a significant role in solving the global antibiotic crisis by facilitating the targeted and timely administration of ...